The 1600014C10Rik Activators denote a specialized chemical class that is designed to interact with the protein encoded by the 1600014C10Rik gene. The compounds within this class are defined by their ability to bind to the protein and enhance its activity within the cellular environment. These activators are structurally diverse, yet they share a common functionality in that they can engage with the protein in a manner that leads to an increase in its natural activity. The interaction between the activators and the protein is highly specific, which allows for the precision modulation of the protein's role in cellular processes. Upon binding, these activators can induce a conformational change in the protein, which can either directly activate its catalytic function or promote interactions with other proteins or substrates, thereby amplifying signaling pathways or biochemical reactions in which the 1600014C10Rik protein is a critical component.
The ability of 1600014C10Rik Activators to modulate protein function is a testament to the intricate design of these molecules, which allows them to navigate the complex intracellular milieu and impart a direct influence on their target. The activation process initiated by these compounds can lead to a series of intracellular changes, impacting various aspects of cell biology that are regulated by the 1600014C10Rik protein. The specificity of the interaction is central to the function of these activators, as it ensures that the upregulation of activity is confined to the intended protein, thereby minimizing off-target effects and maintaining the integrity of other cellular functions. By engaging with the 1600014C10Rik protein, these activators can facilitate the protein's role in signal transduction or other regulatory mechanisms, thereby playing a crucial role in the fine-tuning of cellular activities. In essence, the 1600014C10Rik Activators chemical class is characterized by a series of compounds that can effectively and selectively enhance the activity of the 1600014C10Rik protein, thereby influencing the broader spectrum of cellular processes in which this protein is involved.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, which degrade cAMP and cGMP. By preventing cAMP degradation, IBMX indirectly increases PKA activity, which may enhance the phosphorylation and activity of "Protein NM_001085385". | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates Protein Kinase C (PKC), which could phosphorylate "Protein NM_001085385" if it is a substrate of PKC, thus potentially enhancing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations, potentially activating calcium-dependent protein kinases like CaMK, which could then enhance the activity of "Protein NM_001085385". | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits multiple protein kinases and could indirectly enhance the activity of "Protein NM_001085385" by inhibiting negative regulatory kinases that suppress its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K, leading to reduced Akt phosphorylation. This could enhance "Protein NM_001085385" activity if Akt negatively regulates "Protein NM_001085385" by phosphorylation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is an inhibitor of protein phosphatases PP1 and PP2A. Inhibition of these phosphatases could result in increased phosphorylation levels of "Protein NM_001085385", thereby enhancing its activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels, potentially enhancing PKA activity and subsequently the activity of "Protein NM_001085385" if it is a PKA substrate. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits PDEs, leading to an increase in cGMP levels, which could enhance PKG activity. If "Protein NM_001085385" is a PKG substrate, this could lead to its enhanced activity. | ||||||